Navigation Links
Anti-anxiety treatment found effective in lowering blood pressure

Acute blood pressure (BP) increase is one of the most common causes for referral to the emergency room. In most patients the condition, although urgent, is not an emergency, and intravenous treatment is not required//. There are no guidelines on how to treat patients with acute BP elevation or excessive hypertension. Anxiety is a common cause of excessive hypertension and therefore antianxiety treatment may be beneficial in these patients.

Researchers from Israel suggest that it seems more physiologic to treat the cause of the BP increase rather than to use BP-lowering agents for all patients. Acute BP elevation may results due to a number of reasons, however, in many patients the cause of the BP elevation is unknown and panic attack or anxiety may be the cause. In these patients antianxiety treatment may be beneficial.

Researchers from the Tel Aviv University, Sackler School of Medicine, Israel, designed a study to compare the efficacy and safety of antianxiety treatment with the common practice of sublingual captopril administration in patients who were referred to the emergency room because of excessive hypertension without evidence of acute target organ damage. Thirty-six patients were randomized to receive either oral diazepam or sublingual captopril, Blood pressure (BP) and heart rate were recorded hourly for 3 h. Both treatments were found to decrease BP significantly in the study group.

The researchers, writing in the September issue of American Journal of Hypertension, conclude that antianxiety treatment is effective in lowering BP in patients with excessive hypertension. Thus, anxiolytic treatment may be considered in patients with excessive hypertension without acute target organ damage. However, further large placebo controlled studies are required to prove the benefit of anxiolytic agents. The researchers warn that despite the beneficial effect of antianxiety treatment it is important not to generalize the findings to all pati ents with excessive hypertension, as they were very careful to exclude patients with acute target organ impairment and patients with pains that required analgesics. Thus, this treatment should be reserved for patients who present with excessive BP values with no evidence of need for emergency treatment.
'"/>




Related medicine news :

1. Thyroid hormone treatment hastens recovery after cardiac surgery
2. Feeding channel created by malaria parasite - a new target for malaria treatments
3. Now umbilical cord helps in stroke treatment.
4. Now AIDS treatment comes dirt-cheap
5. Breast cancer treatment to be determined by gene test
6. Hemopurifier may revolutionise AIDS treatment
7. New drug helps boost cancer treatment
8. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
9. Experimental treatment for Ebola Virus Shows promising results in mice
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. New dimension in the treatment of female sexual dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... , ... October 12, 2017 , ... HMP , ... recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ ... on October 11, 2017. , The annual award competition recognizes editorial and design excellence ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... On ... holding a treadmill relay – Miles by Moonlight to raise money for the American ... $300 or more. , Teams will work together to keep their treadmills moving ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... the nation's first interactive health literacy software tool, and the Cancer Patient Education ... of cancer patient education, today announce a new strategic alliance. , As ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... wound care advancements to physician colleagues, skilled nursing facility medical directors and other ... Treacherous Waters of Wound Care." , "At many of these conferences we get ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/19/2017)... Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company ... destruction of targeted tissues, announced three leadership team developments today:   ... PhD ... ... Veteran medical device executive Josh ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis ... global supply chains, has published the first annual edition of its Global ... more than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that ... ... Risk & Performance Index ...
Breaking Medicine Technology: